₹32.96
−4.99%BSE close, 16 Nov 2026
+94.45%
GlobalSpace Technologies Limit is a small cap company in the Healthcare sector, listed on BSE under the symbol GSTL (BSE code 540654). At ₹32.96 a share, the market values the whole company at ₹113 crore.
In FY26, it reported sales of ₹21 crore and a net loss of ₹0 crore, an operating margin of 5.9%. Over the last three years, sales fell 7.1% a year.
The market values the company at 2.61 times its book value; its return on equity is -2.8% and its borrowings are 0.27 times its equity.
Promoters hold 27.83% of the shares, and have pledged 81.3% of their holding. Foreign institutions hold 0.00%, and domestic institutions, mutual funds among them, 0.00%.
Over the past year the share price has risen 88.3%, and it is 17.9% below its 52-week high.
Companies of a similar size in the same sector include ABATE AS INDUSTRIES, CHOKSI ASIA, LACTOSE (INDIA) and TYCHE INDUSTRIES.
₹ crore. Standalone figures: the company files no consolidated results.
| Line | 6M to Mar 2023 | 6M to Sep 2023 | 6M to Mar 2024 | Sep 2024 | 6M to Mar 2025 | 6M to Sep 20251 | 6M to Mar 2026 |
|---|
The same sector (Healthcare), nearest in size.
| Company | Price | Market cap | P/E | ROE | Sales growth | 1Y |
|---|---|---|---|---|---|---|
| GlobalSpace Technologies Limit | ₹32.96 | ₹113 cr | n/a | -2.8% | −68.10% | +88.34% |
| ABATE AS INDUSTRIES | ₹7.33 | ₹116 cr | n/a | n/a | n/a | −57.23% |
| CHOKSI ASIA | ₹200.20 | ₹114 cr | n/a | n/a | n/a | +83.92% |
| LACTOSE (INDIA) | ₹87.35 | ₹110 cr | n/a | n/a | n/a | −22.80% |
| TYCHE INDUSTRIES | ₹103.58 | ₹106 cr | n/a | n/a |
The financial results for the period ended September 30, 2026.
The financial results for the period ended September 30, 2026.
Written from the company's filings with NSE and the exchanges' daily prices. For information only, not a recommendation to buy, sell or hold any security.
| 6M to Sep 2026 |
|---|
| Sales | 20.3 | 10.1 | 13.8 | 10.5 | 6.4 | 7.9 | 12.8 | 2.5 |
|---|---|---|---|---|---|---|---|---|
| Expenses | 17.8 | 8.8 | 12.7 | 9.1 | 9.0 | 8.0 | 11.5 | 3.9 |
| Operating profit | 2.5 | 1.3 | 1.1 | 1.4 | −2.6 | −0.1 | 1.4 | −1.4 |
| Operating margin | 12.1% | 12.8% | 8.2% | 13.4% | -40.3% | -1.3% | 10.6% | -53.8% |
| Other income | 0 | 0 | 1.1 | 0.0 | 0 | −0.0 | 0.1 | 0.2 |
| Interest | 0.3 | 0.4 | 0.6 | 0.7 | 0.2 | 0.5 | 0.5 | 0.4 |
| Depreciation | 0.3 | 0.5 | 0.5 | 0.4 | 0.5 | 0.3 | 0.4 | 0.3 |
| Profit before tax | 1.9 | 0.3 | 1.2 | 0.3 | −3.3 | −0.9 | 0.6 | −1.9 |
| Tax | 0.6 | 0.1 | 0.4 | 0.1 | −0.2 | −0.0 | 0 | 0 |
| Net profit | 1.3 | 0.2 | 0.8 | 0.2 | −3.1 | – | 0.6 | −1.9 |
| EPS (₹) | 1.48 | 0.23 | 0.88 | 0.15 | -1.95 | – | 0.39 | -1.16 |
₹ crore, financial years to March.
| Line | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Sales | 25.8 | 23.9 | 16.9 | 20.7 |
| Expenses | 22.4 | 21.5 | 18.1 | 19.5 |
| Operating profit | 3.4 | 2.4 | −1.2 | 1.2 |
| Operating margin | 13.2% | 10.1% | -6.9% | 5.9% |
| Other income | 0.0 | 1.1 | 0.0 | 0.1 |
| Interest | 0.7 | 1.0 | 1.0 | 0.9 |
| Depreciation | 0.5 | 1.1 | 0.9 | 0.7 |
| Profit before tax | 2.2 | 1.5 | −3.0 | −0.3 |
| Tax | 0.6 | 0.5 | −0.1 | −0.0 |
| Net profit | 1.7 | 1.0 | −2.9 | −0.3 |
| EPS (₹) | 1.94 | 1.11 | -1.80 | -0.17 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY23 | FY24 | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|---|---|
| From operations | −5.8 | 2.1 | −24.1 | 2.4 | −4.4 |
| From investing | −2.2 | −0.5 | −0.3 | −0.1 | 0.0 |
| From financing | 7.9 | −1.5 | 24.4 | −2.3 | 4.2 |
| Spent on fixed assets | – | – | −0.2 | −0.1 | −0.0 |
| Free cash flow | – | – | −24.2 | 2.3 | −4.4 |
Margins, returns, debt, tax and cash.
| Line | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Net margin | 6.4% | 4.2% | -17.0% | -1.4% |
| Operating margin | 13.2% | 10.1% | -6.9% | 5.9% |
| Return on equity | – | – | -6.3% | -0.6% |
| Return on capital employed | – | – | -3.8% | 1.2% |
| Return on assets | – | – | -4.7% | -0.4% |
| Debt to equity | – | – | 0.15 | 0.15 |
| Interest coverage | 4.10 | 2.50 | -2.10 | 0.70 |
| Debt to assets | – | – | 0.11 | 0.10 |
| Current ratio | – | – | 3.21 | 2.24 |
| Quick ratio | – | – | 2.55 | 2.06 |
| Cash ratio | – | – | 0.01 | 0.00 |
| Asset turnover | – | – | 0.28 | 0.29 |
| Fixed asset turnover | – | – | 4.61 | 6.72 |
| Inventory turnover | – | – | 1.30 | 2.80 |
| Receivables turnover | – | – | 5.90 | 4.30 |
| Gross margin | – | – | 22.8% | 37.9% |
| Cash from operations to profit | -350.0% | 205.0% | – | – |
| Effective tax rate | 25.0% | 31.8% | – | – |
| −22.18% |
| VEERHEALTH CARE | ₹52.93 | ₹106 cr | n/a | n/a | n/a | +192.43% |
|---|
| STAR IMAGING AND PATH LAB LIMI | ₹59.04 | ₹103 cr | n/a | n/a | n/a | −57.53% |
|---|
| Cian Healthcare | ₹40.76 | ₹102 cr | n/a | n/a | n/a | +442.74% |
|---|
| PHARMAIDS PHARMACEUTICALS | ₹28.07 | ₹99 cr | n/a | n/a | n/a | −40.33% |
|---|
Resignation of Ms Heta Dipen Desai as Company Secretary & Compliance Officer of the company w.e.f. December 04, 2026.
Receipt of Legal Notice
SDD Compliance certificate for the Quarter ended September 30, 2026.
A copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results.
Appointment of Ms Ms. Ranjana Malpani and Mr. Shravan Talvar as Non- Executive Independent Director of the company w.e.f. October 01, 2026.
The Amendment to AOA/MOA of the company.
Proceedings of Annual General Meeting held on September 30, 2026
Revised financial results for half year and year ended March 31, 2026
Appointment of Ms. Ranjana Malpani as Non- Executive Independent Director of the company w.e.f. September 18, 2026.
Outcome of Board Meeting held on September 18, 2026.